Main > CARDIOLOGY (OK) > USA. Amg. HeFH/HoFH>Treat.>OK

---

USA. Amg. HeFH/HoFH>Treat.>OK's subsections
(*) Approved Also in AU; CA & JP
(*) EU Approval Date: 2018. 05.16
(*) USA Approval Date: 2017. 12.01
>EvolocuMAb Inj.
Company
Heart Attack Risk Reduction
HeFH: HEterozygous Familial Hyperch
HoFH: HOmozygous Familial Hyperchol
Mechanism: PCSK9 Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2016. 07.26.
RTM
RTM Web-Site

USA. Amg. HeFH/HoFH>Treat.>OK's products
This section has no products